Off-Label Prescribing and Polypharmacy Minimizing the Risks

被引:0
|
作者
Leahy, Laura G. [1 ,2 ]
机构
[1] APNSolut LLC, 123 Egg Harbor Rd,Suite 703, Sewell, NJ 08080 USA
[2] APNSolut LLC, Psychopharmacol, 123 Egg Harbor Rd,Suite 703, Sewell, NJ 08080 USA
关键词
RANDOMIZED-CONTROLLED-TRIALS; DRUG-USE; DISORDER; MULTICENTER; TOPIRAMATE; PRAZOSIN;
D O I
10.3928/02793695-20170210-02
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Off-label prescribing and polypharmacy are commonplace in today's health care environment. Patients are treated with multiple medications obtained through multiple providers, and all too frequently, there is no collaboration amongst professionals. Nurses can address these issues by educating themselves and their patients regarding medication indications and uses, side effects, risks, and benefits. By exploring a patient's medication reconciliation, including over-the-counter agents, and identifying the U.S. Food and Drug Administration-approved indications, as well as potential off-label uses and overlapping side effects of the medications prescribed, nurses can facilitate collaboration among prescribers to reduce polypharmacy, minimize medication side effects, and alleviate drug-drug interactions, while improving patient outcomes and quality of life. [Journal of Psychosocial Nursing and Mental Health Services, 55(2), 17-22.]
引用
收藏
页码:17 / 22
页数:6
相关论文
共 50 条
  • [21] Paediatric Off-Label Prescribing in the USA
    不详
    [J]. PHARMACEUTICAL MEDICINE, 2019, 33 (06) : 533 - 534
  • [22] Assessment off-label prescribing in dermatology
    Picard, D
    Carvalho, P
    Bonnavia, C
    Louin, L
    Josset, V
    Lauret, P
    Joly, P
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2003, 130 (05): : 507 - 510
  • [24] Off-Label Prescribing in Older Patients
    Jackson, Stephen H. D.
    Jansen, Paul A. F.
    Mangoni, Arduino A.
    [J]. DRUGS & AGING, 2012, 29 (06) : 427 - 434
  • [25] Off-label prescribing during pregnancy
    Rayburn, WF
    Farmer, KC
    [J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1997, 24 (03) : 471 - &
  • [26] Ongoing challenges of off-label prescribing
    Day, Richard O.
    [J]. AUSTRALIAN PRESCRIBER, 2023, 46 (04) : 86 - 89
  • [27] Off-Label Prescribing in Pediatric Outpatients
    Palmaro, Aurore
    Bissuel, Raphael
    Renaud, Nicholas
    Durrieu, Genevieve
    Escourrou, Brigitte
    Oustric, Stephane
    Montastruc, Jean-Louis
    Lapeyre-Mestre, Maryse
    [J]. PEDIATRICS, 2015, 135 (01) : 49 - 58
  • [28] Off-label prescribing in a French hospital
    Audrey Cras
    Marie-Agnès Conscience
    Gérald Rajzbaum
    Agnès Lillo-Le Louët
    Nathalie Lopez
    Isabelle Tersen
    Yvonnick Bezie
    [J]. Pharmacy World & Science, 2007, 29 : 97 - 100
  • [29] Off-label prescribing in a French hospital
    Cras, Audrey
    Marie-Agnes Conscience
    Rajzbaum, Gerald
    Louet, Agnes Lillo-Le
    Lopez, Nathalie
    Tersen, Isabelle
    Bezie, Yvonnick
    [J]. PHARMACY WORLD & SCIENCE, 2007, 29 (02): : 97 - 100
  • [30] The Many Sides of Off-Label Prescribing
    Epstein, R. S.
    Huang, S-M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (05) : 755 - 758